Indian pharma stocks tumble as Trump signals tariffs on drug imports

Indian pharmaceutical stocks slumped on Wednesday after US President Donald Trump renewed his threat to impose sweeping tariffs on all pharmaceutical imports, an announcement that sent shockwaves through drug industry in India, which heavily relies on exports to the US.

The Nifty Pharma index dropped 1.7 per cent, dragging the broader Nifty 50 benchmark down by 0.52 per cent as of 9.20 am IST. All 20 constituents of the pharma index were trading in the red.

Gland Pharma, Lupin, and Zydus Lifesciences were among the worst hit, plunging between 3 per cent and 5 per cent. Heavyweights Sun Pharma and Cipla also declined, slipping 1.69 per cent and 1.87 per cent, respectively.
US a key market for Indian generics

India exports a significant volume of generic drugs—low-cost alternatives to branded pharmaceuticals—to the United States, which accounts for roughly one-third of the country’s overall pharma exports. Currently, these products face minimal to no tariffs in the US, while India levies around 10 per cent on pharmaceutical imports from America, according to industry analysts.

Speaking at the National Building Museum in Washington late Tuesday, Trump indicated that pharmaceutical imports would soon face hefty new tariffs.

“Tariffs on pharma will be there because we don’t make our own pharma drugs; they are made in another country. The same packet in the US is priced at USD 10 or more. We are going to tariff pharma in such a way that companies will come rushing to us very soon. The advantage we have is, we are very big market. Very shortly, will announce a major tariff on pharma, and when these companies hear that, they will leave China and other countries because most of their products are sold here. And they will be opening their plants here,” Trump said.

Related Posts

  • Pharma
  • April 28, 2025
  • 4 views
Doctor not liable for prescribing costly drug: HC

Cuttack:  Orissa high court has ruled that a doctor should not be held criminally liable for prescribing a particular drug of any pharmaceutical company for treatment of a disease like…

  • Pharma
  • April 28, 2025
  • 31 views
878 Tramadol capsules being smuggled in Scorpio seized, three arrested

Bansur: Narayanpur police station has busted a drug smuggling racket. Police have recovered 878 Tramadol capsules from a Scorpio. Three people have been arrested in this case. According to police station…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Doctor not liable for prescribing costly drug: HC

Doctor not liable for prescribing costly drug: HC

878 Tramadol capsules being smuggled in Scorpio seized, three arrested

878 Tramadol capsules being smuggled in Scorpio seized, three arrested

Doctor not criminally liable for prescribing costly drug: Orissa High Court

Doctor not criminally liable for prescribing costly drug: Orissa High Court

Merger of Suven Pharma, Cohance Lifesciences to take effect from May 1

Merger of Suven Pharma, Cohance Lifesciences to take effect from May 1

Dr Lal PathLabs Q4 profit rises 81% on volume growth, geographic expansion

Dr Lal PathLabs Q4 profit rises 81% on volume growth, geographic expansion

Lupin-led price cut slashes cost of key TB drug pretomanid by 25%

Lupin-led price cut slashes cost of key TB drug pretomanid by 25%